Selective T Cell Costimulation Modulator [EPC]

137679 reported adverse events

Drugs of this class: ABATACEPT

These side effects are most commonly reported by patients taking drugs of the Selective T Cell Costimulation Modulator [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 38999
1 RHEUMATOID ARTHRITIS 24346
2 PAIN 21928
3 ARTHRALGIA 21292
4 JOINT SWELLING 20569
5 FATIGUE 14480
6 CONTRAINDICATED PRODUCT ADMINISTERED 14008
7 RASH 13296
8 DRUG INTOLERANCE 13209
9 OFF LABEL USE 12112
See all common reactions for Selective T Cell Costimulation Modulator [EPC]

Drugs of the Selective T Cell Costimulation Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 306 0.9134
1 RHEUMATOID FACTOR NEGATIVE 137 0.7829
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5434 0.7746
3 RHEUMATOID FACTOR POSITIVE 4277 0.7511
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 486 0.7375
5 RED BLOOD CELL SEDIMENTATION RATE 205 0.7374
6 SWOLLEN JOINT COUNT INCREASED 2226 0.7230
7 PEMPHIGUS 8847 0.7209
8 DEVICE SAFETY FEATURE ISSUE 669 0.7094
9 RHEUMATIC FEVER 2990 0.6934
See all enriched reactions for Selective T Cell Costimulation Modulator [EPC]